top of page
Search
Writer's picture
Kuria Therapeutics
  • Mar 17

FDA Pre-IND Consultation Completed

Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease LITTLE ROCK,...

bottom of page